Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Oncotarget ; 7(28): 43762-43778, 2016 Jul 12.
Article in English | MEDLINE | ID: mdl-27248325

ABSTRACT

Breast cancer is a major global health problem with high incidence and case fatality rates. The use of magnetoliposomes has been suggested as an effective therapeutic approach because of their good specificity for cancers. In this study, we developed two novel magnetoliposomes, namely, Gemcitabine-containing magnetoliposome (GML) and Oxaliplatin-containing magnetoliposome (OML). These magnetoliposomes were combined (CGOML) was used to treat breast cancer under an external magnetic field. Biosafety test results showed that GML and OML were biologically safe to blood cells and did not adversely affect the behavior of mice. Pharmacokinetic and tissue distribution studies indicated that both magnetoliposomes exhibited stable structures and persisted at the target area under an external magnetic field. Cell and animal experiments revealed that CGOML can markedly suppress the growth of MCF-7 cells, and only the CGOML group can minimize the tumor size among all the groups. Finally, CGOML can significantly inhibit MCF-7cell growth both in vitro and vivo by activating the apoptotic signaling pathway of MCF-7 cells.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Breast Neoplasms/drug therapy , Drug Delivery Systems/methods , Magnetite Nanoparticles/administration & dosage , Animals , Deoxycytidine/administration & dosage , Deoxycytidine/adverse effects , Deoxycytidine/analogs & derivatives , Female , Humans , Liposomes , Mice , Mice, Nude , Organoplatinum Compounds/administration & dosage , Organoplatinum Compounds/adverse effects , Oxaliplatin , Xenograft Model Antitumor Assays , Gemcitabine
2.
PLoS Biol ; 12(11): e1001998, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25406061

ABSTRACT

Diseases of protein folding arise because of the inability of an altered peptide sequence to properly engage protein homeostasis components that direct protein folding and function. To identify global principles of misfolding disease pathology we examined the impact of the local folding environment in alpha-1-antitrypsin deficiency (AATD), Niemann-Pick type C1 disease (NPC1), Alzheimer's disease (AD), and cystic fibrosis (CF). Using distinct models, including patient-derived cell lines and primary epithelium, mouse brain tissue, and Caenorhabditis elegans, we found that chronic expression of misfolded proteins not only triggers the sustained activation of the heat shock response (HSR) pathway, but that this sustained activation is maladaptive. In diseased cells, maladaptation alters protein structure-function relationships, impacts protein folding in the cytosol, and further exacerbates the disease state. We show that down-regulation of this maladaptive stress response (MSR), through silencing of HSF1, the master regulator of the HSR, restores cellular protein folding and improves the disease phenotype. We propose that restoration of a more physiological proteostatic environment will strongly impact the management and progression of loss-of-function and gain-of-toxic-function phenotypes common in human disease.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Cystic Fibrosis/etiology , DNA-Binding Proteins/genetics , Proteostasis Deficiencies/genetics , Transcription Factors/genetics , Animals , Antineoplastic Agents, Alkylating/therapeutic use , Caenorhabditis elegans , Cell Line , Cystic Fibrosis/drug therapy , Cystic Fibrosis/metabolism , DNA-Binding Proteins/metabolism , Diterpenes/therapeutic use , Drug Evaluation, Preclinical , Epoxy Compounds/therapeutic use , Gene Silencing , Heat Shock Transcription Factors , Humans , Intramolecular Oxidoreductases/genetics , Intramolecular Oxidoreductases/metabolism , Mice, Transgenic , Organoids , Phenanthrenes/therapeutic use , Prostaglandin-E Synthases , Protein Folding , Respiratory Mucosa/metabolism , Stress, Physiological , Transcription Factors/metabolism
3.
Int J Nanomedicine ; 9: 4533-50, 2014.
Article in English | MEDLINE | ID: mdl-25288882

ABSTRACT

Magnetoliposomes are phospholipid vesicles encapsulating magnetic nanoparticles that can be used to encapsulate therapeutic drugs for delivery into specific organs. Herein, we developed magnetoliposomes containing recombinant human IFNα2b, designated as MIL, and evaluated this combination's biological safety and therapeutic effect on both cellular and animal hepatocellular carcinoma models. Our data showed that MIL neither hemolyzed erythrocytes nor affected platelet-aggregation rates in blood. Nitroblue tetrazolium-reducing testing showed that MIL did not change the absolute numbers or phagocytic activities of leukocytes. Acute-toxicity testing also showed that MIL had no devastating effect on mice behaviors. All the results indicated that the nanoparticles could be a safe biomaterial. Pharmacokinetic analysis and tissue-distribution studies showed that MIL maintained stable and sustained drug concentrations in target organs under a magnetic field, helped to increase bioavailability, and reduced administration time. MIL also dramatically inhibited the growth of hepatoma cells. Targeting of MIL in the livers of nude mice bearing human hepatocellular carcinoma showed that MIL significantly reduced the tumor size to 38% of that of the control group. Further studies proved that growth inhibition of cells or tumors was due to apoptosis-signaling pathway activation by human IFNα2b.


Subject(s)
Drug Carriers/chemistry , Immunologic Factors/pharmacology , Interferon-alpha/pharmacology , Liposomes/chemistry , Liver Neoplasms, Experimental/pathology , Magnetite Nanoparticles/chemistry , Animals , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Drug Carriers/toxicity , Drug Evaluation, Preclinical , Female , Humans , Immunologic Factors/chemistry , Immunologic Factors/pharmacokinetics , Immunologic Factors/toxicity , Interferon alpha-2 , Interferon-alpha/chemistry , Interferon-alpha/pharmacokinetics , Interferon-alpha/toxicity , Liposomes/toxicity , Magnetite Nanoparticles/toxicity , Male , Mice , Mice, Inbred ICR , Rabbits , Rats , Rats, Sprague-Dawley , Recombinant Proteins/chemistry , Recombinant Proteins/pharmacokinetics , Recombinant Proteins/pharmacology , Recombinant Proteins/toxicity , Tissue Distribution
4.
Sci Rep ; 4: 4575, 2014 Apr 03.
Article in English | MEDLINE | ID: mdl-24694579

ABSTRACT

Synaptotagmin 1 (Syt1) is a major Ca(2+)-sensor that evokes neurotransmitter release. Here we used site-specific fluorescence resonance energy transfer (FRET) assay to investigate the effects of Syt1 on SNAREpin assembly. C2AB, a soluble version of Syt1, had virtually no stimulatory effect on the rate of the FRET at N-terminus of SNARE complex both with and without Ca(2+), indicating C2AB does not interfere with the initial nucleation of SNARE assembly. However, C2AB-Ca(2+) accelerated the FRET rate significantly at membrane proximal region, indicating C2AB-Ca(2+) promotes the transition from a partially assembled SNARE complex to the fusion-competent SNAREpin. Similar enhancement was also observed at the end of the transmembrane domain of SNARE proteins. The stimulatory effect disappeared if there was no membrane or only neutral membrane present.


Subject(s)
Calcium/metabolism , SNARE Proteins/metabolism , Synaptotagmin I/metabolism , Fluorescence Resonance Energy Transfer , Humans , Light , Lipid Bilayers/chemistry , Lipid Bilayers/metabolism , Models, Molecular , Protein Structure, Tertiary , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , SNARE Proteins/chemistry , SNARE Proteins/genetics , Scattering, Radiation , Synaptotagmin I/chemistry , Synaptotagmin I/genetics
5.
Nucleic Acids Res ; 41(Database issue): D553-60, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23197658

ABSTRACT

Disease and Gene Annotations database (DGA, http://dga.nubic.northwestern.edu) is a collaborative effort aiming to provide a comprehensive and integrative annotation of the human genes in disease network context by integrating computable controlled vocabulary of the Disease Ontology (DO version 3 revision 2510, which has 8043 inherited, developmental and acquired human diseases), NCBI Gene Reference Into Function (GeneRIF) and molecular interaction network (MIN). DGA integrates these resources together using semantic mappings to build an integrative set of disease-to-gene and gene-to-gene relationships with excellent coverage based on current knowledge. DGA is kept current by periodically reparsing DO, GeneRIF, and MINs. DGA provides a user-friendly and interactive web interface system enabling users to efficiently query, download and visualize the DO tree structure and annotations as a tree, a network graph or a tabular list. To facilitate integrative analysis, DGA provides a web service Application Programming Interface for integration with external analytic tools.


Subject(s)
Databases, Genetic , Disease/genetics , Genes , Molecular Sequence Annotation , Humans , Internet , Proteins/genetics , Proteins/metabolism , Vocabulary, Controlled
6.
BMC Syst Biol ; 6: 19, 2012 Mar 16.
Article in English | MEDLINE | ID: mdl-22423977

ABSTRACT

BACKGROUND: Network motifs, recurring subnetwork patterns, provide significant insight into the biological networks which are believed to govern cellular processes. METHODS: We present a comparative network motif experimental approach, which helps to explain complex biological phenomena and increases the understanding of biological functions at the molecular level by exploring evolutionary design principles of network motifs. RESULTS: Using this framework to analyze the SM (Sec1/Munc18)-SNARE (N-ethylmaleimide-sensitive factor activating protein receptor) system in exocytic membrane fusion in yeast and neurons, we find that the SM-SNARE network motifs of yeast and neurons show distinct dynamical behaviors. We identify the closed binding mode of neuronal SM (Munc18-1) and SNARE (syntaxin-1) as the key factor leading to mechanistic divergence of membrane fusion systems in yeast and neurons. We also predict that it underlies the conflicting observations in SM overexpression experiments. Furthermore, hypothesis-driven lipid mixing assays validated the prediction. CONCLUSION: Therefore this study provides a new method to solve the discrepancies and to generalize the functional role of SM proteins.


Subject(s)
Exocytosis , Models, Biological , Munc18 Proteins/metabolism , SNARE Proteins/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Cell Membrane/metabolism , Neurons/cytology , Neurons/metabolism , Qa-SNARE Proteins/metabolism , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , Synapses/metabolism
7.
J Biol Chem ; 285(1): 531-40, 2010 Jan 01.
Article in English | MEDLINE | ID: mdl-19880963

ABSTRACT

The mechanisms by which cytosolic proteins reversibly bind the membrane and induce the curvature for membrane trafficking and remodeling remain elusive. The epsin N-terminal homology (ENTH) domain has potent vesicle tubulation activity despite a lack of intrinsic molecular curvature. EPR revealed that the N-terminal alpha-helix penetrates the phosphatidylinositol 4,5-bisphosphate-containing membrane at a unique oblique angle and concomitantly interacts closely with helices from neighboring molecules in an antiparallel orientation. The quantitative fluorescence microscopy showed that the formation of highly ordered ENTH domain complexes beyond a critical size is essential for its vesicle tubulation activity. The mutations that interfere with the formation of large ENTH domain complexes abrogated the vesicle tubulation activity. Furthermore, the same mutations in the intact epsin 1 abolished its endocytic activity in mammalian cells. Collectively, these results show that the ENTH domain facilitates the cellular membrane budding and fission by a novel mechanism that is distinct from that proposed for BAR domains.


Subject(s)
Adaptor Proteins, Vesicular Transport/chemistry , Adaptor Proteins, Vesicular Transport/metabolism , Cell Membrane/metabolism , Models, Molecular , Animals , Cell Line , Electron Spin Resonance Spectroscopy , Endocytosis , Mice , Mutant Proteins/chemistry , Mutant Proteins/metabolism , Protein Structure, Quaternary , Protein Structure, Secondary , Protein Structure, Tertiary , Structure-Activity Relationship , Transferrin/metabolism , Unilamellar Liposomes/metabolism
8.
Proc Natl Acad Sci U S A ; 106(13): 5141-6, 2009 Mar 31.
Article in English | MEDLINE | ID: mdl-19251653

ABSTRACT

Neurotransmitter release at the synapse requires membrane fusion. The SNARE complex, composed of the plasma membrane t-SNAREs syntaxin 1A and SNAP-25 and the vesicle v-SNARE synaptobrevin, mediates the fusion of 2 membranes. Synaptic vesicles contain unusually high cholesterol, but the exact role of cholesterol in fusion is not known. In this study, cholesterol was found to stimulate SNARE-mediated lipid mixing of proteoliposomes by a factor of 5 at a physiological concentration. Surprisingly, however, the stimulatory effect was more pronounced when cholesterol was on the v-SNARE side than when it was on the t-SNARE side. Site-directed spin labeling and both continuous wave (CW) and pulsed EPR revealed that cholesterol induces a conformational change of the v-SNARE transmembrane domain (TMD) from an open scissors-like dimer to a parallel dimer. When the TMD was forced to form a parallel dimer by the disulfide bond, the rate was stimulated 2.3-fold even without cholesterol, supporting the relevance of the open-to-closed conformational change to the fusion activity. The open scissors-like conformation may be unfavorable for fusion and cholesterol may relieve this inhibitory factor.


Subject(s)
Cholesterol/metabolism , Membrane Fusion , Membrane Lipids/metabolism , SNARE Proteins/metabolism , Electron Spin Resonance Spectroscopy , Humans , Protein Conformation , SNARE Proteins/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...